Skip to main content
. 2022 Mar 1;14(5):1279. doi: 10.3390/cancers14051279

Figure 4.

Figure 4

Correlation of DEFA5 in bone marrow and survival in esophageal carcinoma (EC) patients with neoadjuvant chemotherapy. DEFA5 expression in bone marrow (BM) (n = 82) samples of EC patients with neoadjuvant therapy was assessed by RT-PCR and correlated with overall survival. On the vertical dotted line, the 5-year (60 months) overall survival is shown. The horizontal dotted line at the cumulative survival probability of 0.5 indicates the median survival. (BL: blood, BM: bone marrow).